0001127602-20-017268.txt : 20200519 0001127602-20-017268.hdr.sgml : 20200519 20200519174244 ACCESSION NUMBER: 0001127602-20-017268 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200518 FILED AS OF DATE: 20200519 DATE AS OF CHANGE: 20200519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lingamneni Anila CENTRAL INDEX KEY: 0001808414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 20894915 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0328 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-05-18 0000313143 HAEMONETICS CORP HAE 0001808414 Lingamneni Anila 125 SUMMER STREET BOSTON MA 02110 1 EVP, Chief Technology Officer Common Stock 2020-05-18 4 A 0 1209 A 3390 D Non-qualified Stock Option (Right to Buy) 103.37 2020-05-18 4 A 0 4092 0 A 2027-05-18 Common Stock 4092 4092 D The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. This number includes unvested RSUs previously reported. Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Ms. Lingamneni 2020-05-19